Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review
- PMID: 38359096
- PMCID: PMC10885774
- DOI: 10.1161/CIRCRESAHA.123.324077
Hypertension Related Co-Morbidities and Complications in Women of Sub-Saharan Africa: A Brief Review
Abstract
Hypertension is the leading cause of cardiovascular disease in women, and sub-Saharan African (SSA) countries have some of the highest rates of hypertension in the world. Expanding knowledge of causes, management, and awareness of hypertension and its co-morbidities worldwide is an effective strategy to mitigate its harms, decrease morbidities and mortality, and improve individual quality of life. Hypertensive disorders of pregnancy (HDPs) are a particularly important subset of hypertension, as pregnancy is a major stress test of the cardiovascular system and can be the first instance in which cardiovascular disease is clinically apparent. In SSA, women experience a higher incidence of HDP compared with other African regions. However, the region has yet to adopt treatment and preventative strategies for HDP. This delay stems from insufficient awareness, lack of clinical screening for hypertension, and lack of prevention programs. In this brief literature review, we will address the long-term consequences of hypertension and HDP in women. We evaluate the effects of uncontrolled hypertension in SSA by including research on heart disease, stroke, kidney disease, peripheral arterial disease, and HDP. Limitations exist in the number of studies from SSA; therefore, we will use data from countries across the globe, comparing and contrasting approaches in similar and dissimilar populations. Our review highlights an urgent need to prioritize public health, clinical, and bench research to discover cost-effective preventative and treatment strategies that will improve the lives of women living with hypertension in SSA.
Keywords: cardiovascular diseases; health inequities; kidney diseases; pre-eclampsia; pregnancy.
Conflict of interest statement
Figures
References
-
- Okello S; Muhihi A; Mohamed SF; Ameh S; Ochimana C; Oluwasanu AO; Bolarinwa OA; Sewankambo N; Danaei G, Hypertension prevalence, awareness, treatment, and control and predicted 10-year CVD risk: a cross-sec>onal study of seven communi>es in East and West Africa (SevenCEWA). BMC Public Health 2020, 20 (1), 1706. - PMC - PubMed
-
- Rosendaal NT; Hendriks ME; Verhagen MD; Bolarinwa OA; Sanya EO; Kolo PM; Adenusi P; Agbede K; van Eck D; Tan SS; Akande TM; Redekop W; Schultsz C; Gomez GB, Costs and Cost-Effec>veness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program. PLoS One 2016, 11 (6), e0157925. - PMC - PubMed
-
- Tannor EK; Nyarko OO; Adu-Boakye Y; Owusu Konadu S; Opoku G; Ankobea-Kokroe F; Opare Addo M; Amuzu EX; Ansah GJ; Appiah-Boateng K; Ansong D, Burden of hypertension in Ghana - Analysis of awareness and screening campaign in the Ashan> Region of Ghana. JRSM Cardiovasc Dis 2022, 11, 20480040221075521. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
